Watch for Misleading Clinical Trial Results

Drug marketing often brings up questions about how to determine whether clinical trial results should impact patient care.

Randomized controlled trials (RCTs) are thought to be the strongest studies, since they can suggest "cause and effect" with therapies.

But study design has an important impact on the take-home message...and whether results may be practice-changing.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals